About Genhouse

Get to know us from here
About Genhouse

Genhouse Bio is a clinical-stage biotech company focusing on the development of global next-generation anti-cancer therapeutics, headquartered in the Suzhou Industry Park . The senior management team of Genhouse has multiple years of experience in new drug development, clinical research and corporate management. Genhouse has a clear focus on original innovation and overcoming those “undruggable” targets.

Genhouse has established intergrated in-house drug development platforms. With these platforms, Genhouse has started to build a highly innovative anti-cancer pipeline and out-licensed the ex-China rights of its SHP2 inhibitor GH21 to HUYABIO , an international biotech company. Genhouse will continue to advance more innovative pipeline programs into global development.

  • Validation of the Innovative Pipeline
    In 2020, Genhouse out-licensed the ex-China rights of its SHP2 inhibitor GH21 to HUYABIO International for $280 million of upfront and milestone payments plus royalty, a key validation of Genhouse’s innovation capability. The total deal value ranked in the top of all recent out-licensing deals by China biotech companies.
  • Sustainable Innovation Capability
    Genhouse continues to further develop its in-house drug discovery platforms and to target novel MoA for potential first-in-class therapeutics.
  • Global Reach Capability
    The innovative pipeline of Genhouse focuses on original research with global competencies. Multiple programs in Pipeline 2.0 aim to address unmet medical needs worldwide.

Kuifeng Wang

Founder & CEO

CEO Remarks

By virtue of ten-year experience in translational medicine research, Genhouse has established fully integrated in-house technology platforms to drive the original innovation based on real-world data. Genhouse sets out from clinical-derived real-world discovery, centered around novel MoA and “undruggable” targets, and eventually created a highly innovative pipeline targeting global markets. We firmly believe that talents are the true movers of innovation, and we are actively building the company to attract and retain talents. A first-tier R&D team is the conner stone to realize our strategic goal to constitutively improve our innovation capability and accelerate global development of our pipeline. Genhouse will live on its aspiration to bring more  cutting-edge treatment options to patients worldwide.

Development History
Financing History
  • 2021
    Series A Financing in 2021
  • 2019
    Pre-A Financing in 2019
  • 2018
    Angle Financing in 2018
Program Development
  • 2021
    IND approval of GH35 in China in 2021
  • 2020
    SHP2 program GH21 out-licensing to HUYABIO in 2020
  • 2017
    Transformed into a new drug development company in 2017
    Obtained National High-Tech Enterprise Certificate in 2017
  • 2014
    Founded in 2014 as a CRO company for institutions
Privacy Statement

Genhouse Bio (Suzhou) Ltd. (“Genhouse” or “We”) respects the privacy of visitors (“Users”) to our website www.genhousebio.com (“Site”), so we have developed this website privacy statement (“Privacy Statement”). This Privacy Statement indicates what information we collect about you and how that information is used. We may update the content of the Privacy Statement and suggest reading it regularly when you visit our Site.

Personal Information Collected by Genhouse

When you visit the Site, usually we will not collect any personal information from you. We might track your DNS and analyze the data to obtain understanding on visit trends. However, your identity will always remain anonymous, unless you specifically and knowingly provide it to us. When you provide such information, we will collect your personal information, such as when you contact us through the phone number or email address posted on the Site. But no matter when and how we collect your personal information, we will always provide link to this Privacy Statement. By willingly providing your personal information to us, you make the consent that we could use the information collected according to this Privacy Statement and admit that the information will be transferred from your locale to our office or server.

Information Disclosures and Sharing

Except as provided below, we will not share or sell your Personal Information with third parties unless otherwise stated by this Privacy Statement.

We might share your information according to this Privacy Statement, with Related Party who have consented to follow this Privacy Statement. Your personal information might also be transferred to other Related Party who represents us for purpose stated when we collect those information or other purposes permitted by law, such as Site evaluation, data management or technical support.

We might sell or buy business or assets during our operation. If Genhouse is acquired, merged, reorganized or dissolved or other alike situations happened, personal information might be part of the assets transferred. We may share personal information to respond to duly authorized subpoenas or other lawful information requests of governmental authorities, including to meet national security or law enforcement requirements, to provide Internet security, or where required by law.


We might put a digital tag (more precisely “cookies”) on your hard disk driver for the server to recognize your computer and track usage information. Cookies will not reveal your personal information and you could always stay anonymous to us. The information we collected from Cookies will only be used for internal purpose and improve the service we provided to you through the Site. Users of our Site always have the option of disabling cookies via their browser preferences. If under any circumstances we collected your personal information, we will always inform you with your planned usage, contact and any Third Party that might get this information. All your personal information will maintain secrecy.

Links to Other Websites

If you apply to a job through our Site, you might be directed to other websites operated by Third Party. This Privacy Statement does not extend to any of these websites. Genhouse will not be responsible for any personal information collected by these websites operated by Third Party. Therefore, for any cases that a Third Party collect or use your personal information, Genhouse will not be legally responsible. We advise you to contact those websites directly and get their policies on personal information collection, safety, sharing and disclosure.

Contact Information

If you have any questions about our Privacy Statement, please do not hesitate to contact us at [infor@genhousebio.com].

Effective and Last Updated: April 15th 2021